There are 2934 resources available
EONS - Leadership, combining research with daily practice
Presenter: Hester Vermeulen
Session: EONS 12: Opening session
Resources:
Slides
Webcast
811 - ENTRATA: Randomized, double-blind, phase 2 study of telaglenastat (tela; CB-839) + everolimus (E) vs. placebo (pbo) + E in patients (pts) with advanced/metastatic renal cell carcinoma (mRCC)
Presenter: Chung-Han Lee
Session: Proffered Paper 1 – Genitourinary tumours, non-prostate
Resources:
Abstract
Slides
Webcast
Proffered Paper 1 – Genitourinary tumours, non-prostate - Invited Discussant 901O and 902O
Presenter: Yohann Loriot
Session: Proffered Paper 1 – Genitourinary tumours, non-prostate
Resources:
Slides
Webcast
New frontiers: Spliced variants
Presenter: Martijn Lolkema
Session: Meeting the liquid biopsy family
Resources:
Slides
Webcast
Immunotherapy for locally advanced cancer
Presenter: Benjamin Besse
Session: Next challenges for cancer immunotherapy
Resources:
Slides
Webcast
1056 - Primary 2-year (yr) results of a phase 2, multicenter, randomized, open-label trial of efficacy and safety for talimogene laherparepvec (T-VEC) neoadjuvant (neo) treatment (tx) plus surgery (surg) vs surg in patients (pts) with resectable stage IIIB-IVM1a melanoma
Presenter: Reinhard Dummer
Session: Proffered Paper – Melanoma and other skin tumours
Resources:
Abstract
Slides
Webcast
2898 - Adjuvant immunotherapy with nivolumab (NIVO) alone or in combination with ipilimumab (IPI) versus placebo in stage IV melanoma patients with no evidence of disease (NED): A randomized, double-blind phase 2 trial (IMMUNED)
Presenter: Dirk Schadendorf
Session: Proffered Paper – Melanoma and other skin tumours
Resources:
Abstract
Proffered Paper – Melanoma and other skin tumours - Invited Discussant LBA66, LBA67 and 1310O
Presenter: Bartosz Chmielowski
Session: Proffered Paper – Melanoma and other skin tumours
Resources:
Slides
Webcast
2545 - 5-year survival outcomes of the CheckMate 067 phase 3 trial of nivolumab plus ipilimumab (NIVO+IPI) combination therapy in advanced melanoma
Presenter: James Larkin
Session: Proffered Paper – Melanoma and other skin tumours
Resources:
Abstract
Slides
Webcast
2804 - Combination treatment with cobimetinib (C) and atezolizumab (A) vs pembrolizumab (P) in previously untreated patients (pts) with BRAFV600 wild type (wt) advanced melanoma: primary analysis from the phase 3 IMspire170 trial
Presenter: Ana Arance
Session: Proffered Paper – Melanoma and other skin tumours
Resources:
Abstract
Slides
Webcast